down arrow

Berry Genomics Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000PN7
CNY
11.43
-0.53 (-4.43%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Berry Genomics Co., Ltd.
Why is Berry Genomics Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.32%
  • The company has been able to generate a Return on Capital Employed (avg) of 1.32% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -9.35% and Operating profit at -189.09% over the last 5 years
3
With a fall in PBT of -55.78%, the company declared Very Negative results in Mar 25
  • NET SALES(Q) Lowest at CNY 217.34 MM
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 39.53%, its profits have risen by 27.8%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Berry Genomics Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Berry Genomics Co., Ltd.
15.92%
1.36
60.78%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-9.35%
EBIT Growth (5y)
-189.09%
EBIT to Interest (avg)
-10.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.53
Tax Ratio
8.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.32%
ROE (avg)
1.38%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.75
EV to EBIT
-21.66
EV to EBITDA
-41.76
EV to Capital Employed
3.00
EV to Sales
4.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.83%
ROE (Latest)
-13.92%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at -5.9 %

RAW MATERIAL COST(Y)

Fallen by -1.02% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 1.21%

PRE-TAX PROFIT(Q)

At CNY -1.47 MM has Grown at 96.23%

NET PROFIT(Q)

At CNY -4.19 MM has Grown at 91.34%

-12What is not working for the Company
NET SALES(Q)

Lowest at CNY 217.34 MM

Here's what is working for Berry Genomics Co., Ltd.
Debt-Equity Ratio
Lowest at -5.9 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit
At CNY -1.47 MM has Grown at 96.23%
over average net sales of the previous four periods of CNY -39.02 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -4.19 MM has Grown at 91.34%
over average net sales of the previous four periods of CNY -48.32 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Debtors Turnover Ratio
Highest at 1.21%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -1.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Berry Genomics Co., Ltd.
Net Sales
At CNY 217.34 MM has Fallen at -18.52%
over average net sales of the previous four periods of CNY 266.73 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Net Sales
Lowest at CNY 217.34 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."